Salvage radiotherapy for relapsed non-small cell lung cancer (NSCLC). Is it worth it?
Clinical Oncology(2016)
Abstract
Background to the audit: Effective surgical salvage for recurrent and second primary NSCLC is possible, with reported five-year survival rates between 8% and 40% and 25% to 53%, respectively.1,2
MoreTranslated text
Key words
radiotherapy,cell lung cancer,nsclc,non-small
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined